BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 6:20:00 PM | Browse: 798 | Download: 624
Publication Name World Journal of Hepatology
Manuscript ID 5352
Country Japan
Received
2013-09-02 07:52
Peer-Review Started
2013-09-02 17:26
To Make the First Decision
2013-09-29 10:34
Return for Revision
2013-09-29 18:17
Revised
2013-10-07 05:19
Second Decision
2013-11-04 16:23
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-11-05 08:35
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-11-21 14:27
Publish the Manuscript Online
2013-11-26 22:03
ISSN 1948-5182 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Autobiography
Article Title IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase
Manuscript Source Invited Manuscript
All Author List Tatsuo Miyamura, Tatsuo Kanda, Masato Nakamura, Xia Jiang, Shuang Wu, Shingo Nakamoto, Shigeru Mikami, Nobuo Takada, Fumio Imazeki and Osamu Yokosuka
Funding Agency and Grant Number
Funding Agency Grant Number
Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan
Ministry of Health, Labour and Welfare of Japan
Corresponding Author Tatsuo Kanda, MD, PhD, Associate Professor, Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan. kandat-cib@umin.ac.jp
Key Words Hepatitis C virus; Interleukin 28B; Persistent normal alanine aminotransferase levels; Standard of care; Treatment response
Core Tip Whether the interleukin 28B (IL-28B) genotype affects the treatment response to peginterferon plus ribavirin in hepatitis C virus (HCV)-infected patients with persistently normal alanine aminotransferase (PNALT) is unclear. We examined the association between the IL-28B genotype and treatment response in HCV-infected patients with PNALT. Opinions about the appropriate treatment method for HCV-infected patients with PNALT differ. In the present study, we found that IL-28B rs8099917 TT was associated with SVR in HCV genotype 1-infected Asian patients with PNALT. The determination of IL-28B genotype is important for the successful treatment of HCV genotype 1-infected patients with PNALT.
Publish Date 2013-11-26 22:03
Citation Miyamura T, Kanda T, Nakamura M, Jiang X, Wu S, Nakamoto S, Mikami S, Takada N, Imazeki F, Yokosuka O. IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase. World J Hepatol 2013; 5(11): 635-641
URL http://www.wjgnet.com/1948-5182/full/v5/i11/635.htm
DOI http://dx.doi.org/10.4254/wjh.v5.i11.635
Full Article (PDF) WJH-5-635.pdf
Manuscript File 5352-Review.doc
Answering Reviewers 5352-Answering reviewers.pdf
Copyright License Agreement 5352-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 5352-Language certificate.pdf
Peer-review Report 5352-Peer review(s).pdf
Scientific Editor Work List 5352-Scientific editor work list.doc